Skip to main content

At least sixteen Illinois cases are now linked to the reports of elevated lead levels in recalled cinnamon applesauce pouches. To learn more about the recall, go to If you or a family member consumed this product, consult your health care provider.

IDPH Reports 12 Illinois Counties at an Elevated Community Level for COVID-19

News – Friday, March 24, 2023

CDC Recommends Bivalent Booster this Week for Children 6 months-4 years who Completed Primary Doze of Pfizer Vaccine, Following FDA Authorization

CHICAGO – The Illinois Department of Public Health (IDPH) announced today that the CDC is reporting 12 counties in the state are at an elevated Community Level for COVID-19 this week, compared to nine a week ago. All of those are at a Medium Community Level. There are no counties at High Level compared to one county at High Level last week.

IDPH has recorded a total of 4,100,818 cases and 36,533 deaths, in 102 counties in Illinois since the beginning of the pandemic. The department is reporting 8,560 new confirmed and probable cases of COVID-19 in Illinois in the week ending March 19, and 39 deaths.

IDPH Director Dr. Sameer Vohra said that IDPH welcomes the action by the FDA this week to authorize a bivalent booster shot – and the CDC’s subsequent recommendation of the shots - for children aged 6 months to 4 years old if they completed their primary vaccination series of the Pfizer vaccine with the monovalent vaccine more than two months ago.

“I am pleased that the FDA has authorized and the CDC has expanded its recommendation to allow this category of young children to receive a booster dose of Pfizer’s updated COVID-19 vaccine,” Director Vohra said. “This recommendation now means that all children in this age group are eligible to receive an updated vaccine.  Vaccines remain the best protection to prevent serious illness from COVID-19, and these updated shots are formulated to protect against some of the more recently circulating strains of the disease.  I recommend that parents speak with their children’s health care provider to ensure that their child is up to date on their COVID-19 and other vaccines.”

IDPH is also urging the public to seek treatment for COVID-19 quickly if they test positive for COVID-19. Treatment is widely available and IDPH announced recently that SIU Medicine has made it easier to obtain care by offering a new telehealth test to treat service for COVID-19, in partnership with the department. The service is aimed at providing faster and easier access to treatment for Illinoisans who contract COVID-19. Those who test positive are encouraged to call 217-545-5100 from 7 a.m. to 8 p.m. Monday through Friday and 10 a.m. to 5 p.m. on Saturdays and Sundays to schedule a telehealth appointment to determine if medical treatment is recommended. Appointments will be offered on a first-come, first-serve basis.

Additional options for obtaining tests and treatments can be found at the following test to treat site or by contacting your provider for treatment options, within 5 days of feeling ill.

IDPH is helping Illinoisans stay prepared for any future surge of COVID-19 cases by offering 1 million free COVID-19 rapid antigen tests to Illinois residents in all zip codes outside the City of Chicago through a partnership with the Rockefeller Foundation’s public charity, RF Catalytic Capital and its Project ACT (Access COVID Tests) program.

Through Project ACT, IDPH is distributing up to one million at-home antigen tests to 200,000 Illinois households. You can request one package of five tests on a first-come-first-serve basis at the Project ACT website. The tests will be delivered to the home address.

Free or low cost COVID-19 testing locations are also available throughout the state, including in Chicago, and can be found on the IDPH website’s testing locator page.

The CDC authorized two new bivalent booster vaccines on September 1 that include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an added mRNA component in common between the omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant.

Initially, the Moderna COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 18 years of age and older and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 12 years of age and older. On October 12, the CDC authorized the updated COVID-19 vaccines from Pfizer-BioNTech for children ages 5 through 11 years, and from Moderna for children and adolescents ages 6 through 17 years.

On December 9, the CDC expanded its authorization for bivalent boosters to include children aged 6 months to 5 years. Children ages 6 months through 5 years who previously completed a Moderna primary series can now receive a Moderna bivalent booster 2 months after their final primary series dose. Children ages 6 months through 4 years who are completing a Pfizer primary series will receive a Pfizer bivalent vaccine as their third primary dose.

On March 14, the FDA expanded its authorization for bivalent boosters to include children aged 6 months to 4 years who had previously completed their entire Pfizer primary series with the monovalent vaccine. These children will now to be able to receive the Pfizer bivalent vaccine as their booster, at least 2 months after completion of the primary series with the monovalent vaccine. The children in this age group who completed their Pfizer primary series with the bivalent booster as their 3rd dose (after December 2022) are not eligible for a booster dose of a bivalent vaccine at this time.

The updated boosters are available at pharmacies, hospitals, and other healthcare providers. The best way to locate a vaccine provider near you is to visit and search for bivalent booster availability.

As of last night, 810 individuals in Illinois were reported to be in the hospital with COVID-19.  Of those, 94 patients were in the ICU and 34 patients with COVID-19 were on ventilators.  The preliminary seven-day statewide case rate is 67 COVID-19 cases per 100,000 Illinoisans.

In counties at the Medium Community Level, persons who are elderly or immunocompromised (at risk of severe outcomes) are advised to wear a mask in indoor public places. They should also get up to date on COVID-19 vaccines or get their bivalent booster, if eligible.

IDPH has been supporting pharmacies and healthcare providers in efforts to increase their inventories of the various FDA-authorized treatments. There are over 1,200 treatment locations in Illinois - including all the major retail pharmacies. More than 96.7% of the state’s population is within a 10-mile radius of one of these locations.

A total of 26,093,521 vaccines have been administered in Illinois as of today. The seven-day rolling average of vaccines administered daily is 3,445 doses, including the bivalent booster and first doses.  Since March 17, 24,116 vaccine doses were reported administered in Illinois. Of Illinois’ total population, more than 79% have received at least one COVID-19 vaccine dose, more than 71% have completed their primary series of COVID-19 vaccines, and more than 19% have received the bivalent booster dose, according to data from the Centers for Disease Control and Prevention.

Data indicates that the risk of hospitalization and severe outcomes from COVID-19 is much higher for unvaccinated people than for those who are up to date on their vaccinations.  All data are provisional and are subject to change.  Additional information and COVID-19 data can be found at

Vaccination is the key to ending this pandemic.  To find a COVID-19 vaccination location near you, go to  The federal government has established a new website that provides an all-purpose toolkit with information on how to obtain masks, treatment, vaccines and testing resources for all areas of the country at: